dx 8951 has been researched along with Lung Diseases, Interstitial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aida, T; Kai, K; Kishino, Y; Kumagai, K; Mori, K; Tsuchiya, Y | 1 |
1 other study(ies) available for dx 8951 and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys.
Topics: Animals; Camptothecin; Cathepsin B; Drug Administration Schedule; Female; Immunoconjugates; Lung; Lung Diseases, Interstitial; Macaca fascicularis; Male; Receptor, ErbB-2; Time Factors; Trastuzumab | 2020 |